Immunohistochemical analysis in patients with endometrial carcinoma showed that the decrease of Sirt4, which was reported to inhibit glutamine metabolism, was related to the late stage of endometrial carcinoma.39 This evidence concerns the gene SIRT4 and endometrial carcinoma.